FDA.reportPublic FDA data

PACLITAXEL

Substance profile for UNII P88XT4IS4D, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for PACLITAXEL
Structure render from PubChem CID 36314

Substance Identity#

UNII
P88XT4IS4D
Preferred term
PACLITAXEL
Registry number
33069-62-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C47H51NO14
Chemical structure for PACLITAXEL
Structure render from PubChem CID 36314

Chemical And Database Identifiers#

InChIKey
RCINICONZNJXQF-MZXODVADSA-N
SMILES
CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3=CC=CC=C3)[C@@H]4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7
RxCUI
56946
PubChem
36314
NCIt
C1411
INN ID
7052

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound36314https://pubchem.ncbi.nlm.nih.gov/compound/36314
PubChem InChIKey SearchRCINICONZNJXQF-MZXODVADSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=RCINICONZNJXQF-MZXODVADSA-N
RxNorm56946https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=56946
NCI ThesaurusC1411https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1411
FDA Substance Registration SystemP88XT4IS4Dhttps://precision.fda.gov/uniisearch/srs/unii/P88XT4IS4D

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PACLITAXELACTIVE INGREDIENTP88XT4IS4DABRAXANE (PACLITAXEL) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [ABRAXIS BIOSCIENCE, LLC]24
PACLITAXELACTIVE MOIETYP88XT4IS4DABRAXANE (PACLITAXEL) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [ABRAXIS BIOSCIENCE, LLC]24
PACLITAXELACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]18
PACLITAXELACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [HOSPIRA WORLDWIDE, INC.]18
PaclitaxelACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [SANDOZ INC]9
PaclitaxelACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [SANDOZ INC]9
PACLITAXELACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION, SOLUTION, CONCENTRATE [TEVA PARENTERAL MEDICINES, INC.]7
PACLITAXELACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION, SOLUTION, CONCENTRATE [TEVA PARENTERAL MEDICINES, INC.]7
PACLITAXELACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [ACTAVIS PHARMA, INC.]6
PACLITAXELACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [ACTAVIS PHARMA, INC.]6
PACLITAXELACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]6
PACLITAXELACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC]6
PACLITAXELACTIVE INGREDIENTP88XT4IS4DPACCAL VET-CA1 (PACLITAXEL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ABBOTT LABORATORIES]5
PACLITAXELACTIVE MOIETYP88XT4IS4DPACCAL VET-CA1 (PACLITAXEL) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ABBOTT LABORATORIES]5
PACLITAXELACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]4
PACLITAXELACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [FRESENIUS KABI USA, LLC]4
paclitaxelACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]4
paclitaxelACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]4
PACLITAXELACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION [WG CRITICAL CARE, LLC]2
PACLITAXELACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION [WG CRITICAL CARE, LLC]2
PACLITAXELACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION [MYLAN INSTITUTIONAL LLC ]1
PACLITAXELACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION [MYLAN INSTITUTIONAL LLC ]1
PACLITAXELACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION [ONCO THERAPIES LIMITED ]1
PACLITAXELACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION [ONCO THERAPIES LIMITED ]1
PACLITAXELACTIVE INGREDIENTP88XT4IS4DPACLITAXEL INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1
PACLITAXELACTIVE MOIETYP88XT4IS4DPACLITAXEL INJECTION [PFIZER LABORATORIES DIV PFIZER INC.]1